Name: LUNG Balance Sheet - Pulmonx Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

LUNG - Pulmonx Corp.

USD | NASDAQ | Healthcare

LUNG Balance Sheet - Pulmonx Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash And Short Term Investments
Cash And Equivalents	69.8	70.9	83.5	101.7	148.5	231.6	14.8	4.1	-
Restricted Cash	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	69.8	70.9	83.5	101.7	148.5	231.6	14.8	4.1	-
Receivables
Accounts Receivable	12.1	13.1	12.1	8.7	6.6	4.2	5.5	-	-
Current Assets
Inventory	15.8	16.9	16.7	14.6	16.3	10.7	5.6	-	-
Prepaid Expenses	3.8	4.5	4.2	4.3	4.9
Non-Current Assets
Property, Plant & Equipment Gross	8.9	8.6	8.9	8.3	7.1	3.2	2.3	-	-
Accumulated Depreciation	6.7	5.7	4.9
Current Liabilities
Accounts Payable	3.9	3.8	1.5	1.8	1.6	1.5	2.7	-	-
Short Term Debt	0.1	3.2	2.2	0.1	-
Non-Current Liabilities
Long Term Debt	37.0	34.0	35.1	17.2	17.4	17.4	-	-	-
Operating Lease Liabilities Non-Current	18.1	18.5	1.1	3.8
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	-	-	-	-	-
Supplementary Data
Total Debt	37.1	37.2	37.2	17.3	17.4	17.4	-	-	-
Net debt	(32.7)	(33.7)	(46.3)	(84.4)	(131.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	61.6	69.8	76.5	75.5	74.6	70.9	63.3	63.5	70.2	83.5	94.9	101.6	110.4	101.7	112.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	0.0	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(535.2)	(521.6)	(511.1)	(497.2)	(482.0)	(467.6)	(454.4)	(440.2)	(424.9)	(411.2)	(397.3)	(382.4)	(366.2)	(350.3)	(336.0)	(321.9)	(307.2)
Accumulated Other Comprehensive Income	2.2	2.4	2.2	2.6	2.2	2.1	2.5	2.0	2.0	2.6	1.9	2.0	1.8	1.6	1.4	1.4
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	45.8	54.1	60.0	69.1	77.7	85.8	93.9	101.2	110.5	118.3	125.7	134.0	143.9	154.0	163.5	172.2	182.1
Total Equity	45.8	54.1	60.0	69.1	77.7	85.8	93.9	101.2	110.5	118.3	125.7	134.0	143.9	154.0	163.5	172.2	182.1	193.2

Supplementary Data
Total Debt	37.3	37.1	37.1	37.1	37.2	37.2	37.2	37.2	37.2	37.2	37.2	37.2	37.3	17.3	17.4	17.4	17.4	17.4	20.7	19.3	17.8	0.0	47.1	-	-	-	-	-	-	-	-
Net debt	(24.3)	(32.7)	(39.4)	(38.4)	(37.4)	(33.7)	(26.1)	(26.3)	(32.9)	(46.3)	(57.7)	(64.3)	(73.1)	(84.4)	(95.0)	(104.6)	(111.7)	(131.1)
Working Capital	73.8	81.6	88.4	97.6	99.0	111.8	122.6	129.9	126.6	127.3	126.9	144.9	164.2	150.5	161.4	172.3	183.0	190.5
Book Value	45.8	54.1	60.0	69.1	77.7	85.8	93.9	101.2	110.5	118.3	125.7	134.0	143.9	154.0	163.5	172.2	182.1	193.2
Tangible Book Value	43.4	51.8	57.7	66.8	75.3	83.5	91.6	98.9	108.2	116.0	123.3	131.5	141.5	151.5	161.0	169.6	179.6

Receivables
Accounts Receivable	10.8	12.1	13.8	15.9	14.0	13.1	11.7	11.1	10.5	12.1	10.1	8.9	8.2	8.7	7.2	7.5	6.8	6.6	6.9	6.9	5.1	4.2	5.3	-	-	5.5	-	-	-	-	-